Generic drug approved by FDA (through May 2011): Latanoprost
Latanoprost ophthalmic solution, 0.005% (eqiv. to Xalatan)
MYLAN
Drugs to Watch: Mental Health Conditions
April 11th 2024The FDA is reviewing two novel therapies: a psychedelic-assisted therapy for PTSD with a target action date of Aug. 11, 2024, and therapy for schizophrenia that does not directly block dopamine receptors with an action date of Sept. 26, 2024.